Details of the Drug

General Information of Drug (ID: DMS4XFI)

Drug Name

OPT-302

Indication

Disease Entry	ICD 11	Status	REF
Diabetic macular edema	9B71.02	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Vascular endothelial growth factor C (VEGFC)	TT0QUFV	VEGFC_HUMAN	Inhibitor	[2]
Vascular endothelial growth factor D (VEGFD)	TTOM5H4	VEGFD_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03345082) A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Opthea.